Alvotech (NYSE:ALVO – Get Free Report) is one of 289 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare Alvotech to related companies based on the strength of its analyst recommendations, valuation, risk, profitability, dividends, institutional ownership and earnings. Insider & Institutional Ownership 50.3% […]